U.S. market Closed. Opens in 11 hours 50 minutes

EW | Edwards Lifesciences Corporation Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for EW we got that it has strong fundamentals where Valuation is considered to be slightly overvalued, Profitability is very wealthy, Growth is very good and Health is confidently strong.

Valuation (47%)

Company Industry
P/E Ratio (TTM) 28.35 40.66
PEG Ratio (TTM) 3.28 5.42
P/S Ratio (TTM) 6.96 6.33
P/B Ratio (TTM) 5.62 5.87
P/FCF Ratio (TTM) 77.59 37.81
Price to 5YR AVG Earnings Ratio 34.07 59.41
Price to 5YR AVG FCF Ratio 46.08 36.98

Profitability (80%)

Company Industry
ROA (TTM) 14.59% 4.66%
ROE (TTM) 21.15% 25.49%
Net Profit Margin (TTM) 24.55% 7.22%
ROIC 5YR AVG 29.24% 6.54%

Growth (78%)

4QTR AVG 3YR AVG 5YR AVG
EPS 5.15% 35.75% 20.64%
Revenue -2.18% 12.32% 10.28%
Net Income 5.17% 35.39% 19.91%
Cash Flow 428.28% 26.98% 4.96%

Health (82%)

Company Industry
Current Ratio (TTM) 3.71 2.64
Quick Ratio (TTM) 2.87 1.97
D/E Ratio (TTM) 0.08 0.55
Interest Coverage (TTM) 58.31 2.38
Piotroski F-Score 5 6
Altman Z-Score 12.55 7.18
LTL to 5YR AVG FCF 0.74 3.69
Shares Outstanding Growth 5YR AVG -0.67% 1.65%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙